Andrew Aherrera

Andrew Aherrera is a Partner at Panacea and leads the fund’s public markets strategy that encompasses de novo investments in both publicly traded companies as well as crossover opportunities. Prior to joining Panacea, Andrew was previously Portfolio Manager of Ample Plus, a healthcare-dedicated crossover investment fund with a similar cross-border pedigree that he helped build from the ground up, while simultaneously maintaining an operational role spanning business development, alliance management, and capital markets efforts at the fund’s biotech incubation engine. Andrew began his investment career at RA Capital, primarily covering CNS, hepatology, and oncology therapeutic areas.

Andrew graduated from the combined MD/MBA program at Tufts University School of Medicine, where he garnered AOA Honors and matched into Plastic Surgery at New York Presbyterian/Weill Cornell & Columbia University Medical Centers.